TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmapress Oy
Closing information (x1000 SEK)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover |
10,835
|
11,700
|
12,597 |
Financial expenses | 0 | ||
Earnings before taxes |
670
|
497
|
630 |
Total assets |
6,412
|
6,094
|
5,856 |
Current assets |
3,635
|
4,927
|
4,531 |
Current liabilities |
1,212
|
1,081
|
977 |
Equity capital |
5,191
|
5,013
|
4,869 |
- share capital |
295
|
287
|
274 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency |
81.0%
|
82.3%
|
83.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
6.2%
|
4.2%
|
5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio |
299.9%
|
455.8%
|
463.8% |
Return on equity (ROE) |
12.9%
|
9.9%
|
12.9% |
Change turnover |
-1,212
|
-1,492
|
-977 |
Change turnover % |
-10%
|
-11%
|
-7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.